- In May 2024, Celanese Corporation revealed plans to convert its Polyoxymethylene (POM) manufacturing process into a sustainable practice. The company aims to achieve a net-zero carbon footprint at its production facility in Bishop, Texas, through these initiatives
- In June 2023, BASF SE announced a restructuring of its direct business for Ultraform in Europe. This restructuring involves transferring its POM sales process to long-standing partners Ultrapolymers Group and ALBIS
- In March 2023, Asahi Kasei Asaclean Americas (AKAC), a global supplier of purging compounds and concentrates, announced its merger with Asahi Kasei Plastics North America (APNA), a leading compounder of advanced engineered polymers. The merger, effective from April 1, 2023, resulted in a new firm that includes copolymer POM in its extensive product portfolio
Frequently Asked Questions
The market is segmented based on Segmentation, By Type (Homopolymer POM and Copolymer POM), Application (Dialysis Machine, Handles for Surgical Instruments, Inhalers, Insulin Pen, Medical Trays, Pharmaceutical Closures, and Others) – Industry Trends and Forecast to 2031
.
The Global Medical Polyoxymethylene Market size was valued at USD 122.90 USD Million in 2023.
The Global Medical Polyoxymethylene Market is projected to grow at a CAGR of 6.8% during the forecast period of 2024 to 2031.
The market report covers data from the U.S., Canada, Mexico, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific, Saudi Arabia, U.A.E., South Africa, Egypt, Israel, Rest of Middle East and Africa, Brazil, Argentina, Rest of South America.
